Predictive biomarker evaluation and molecular differentiation for imipridones ONC201 and ONC206.

被引：0
|
作者：
Morrow, Sara [1 ]
Nath, Kirti [1 ]
Zhang, Yiqun [2 ]
Garnett, Mathew J. [3 ]
McDermott, Ultan [3 ]
Benes, Cyril H. [4 ]
Basken, Joel [5 ]
El-Deiry, Wafik S. [2 ]
Allen, Joshua E. [1 ]
Prabhu, Varun V. [1 ]
机构：
[1] Oncoceut Inc, Philadelphia, PA USA
[2] Brown Univ, Providence, RI 02912 USA
[3] Wellcome Trust Sanger Inst, Hinxton, England
[4] Massachusetts Gen Hosp, Boston, MA 02114 USA
[5] Arpeggio Biosci, Boulder, CO USA
来源：
CANCER RESEARCH | 2021年 / 81卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
393
引用
收藏
页数：1
相关论文
共 50 条
  • [1] MOLECULAR DIFFERENTIATION OF IMIPRIDONES ONC201 AND ONC206
    Prabhu, Varun
    Cuoco, Caroline
    Jung, Jinkyu
    Morrow, Sara
    Kawakibi, Abed Rahman
    Willette, Blair
    Day, Marilyn
    Anantharaman, Lakshmi
    Charter, Neil
    Rucker, Joseph
    Doranz, Benjamin
    Basken, Joel
    Stogniew, Martin
    Gilbert, Mark
    Free, R.
    Sibley, David
    Allen, Joshua
    NEURO-ONCOLOGY, 2020, 22 : 68 - 68
  • [2] ClpP drives efficacy and mediates acquired resistance with imipridones ONC201 and ONC206 in glioma in vitro
    Maranto, Cristina
    Foster, Scott
    Lee, Andrew
    Sethna, Phiroze
    Allen, Joshua E.
    Prabhu, Varun V.
    CANCER RESEARCH, 2024, 84 (05)
  • [3] Predictive biomarker evaluation for the anti-cancer imipridone ONC201
    Morrow, Sara
    Prabhu, Varun Vijay
    Allen, Joshua E.
    Oster, Wolfgang
    CANCER RESEARCH, 2020, 80 (16)
  • [4] Differential activation of the integrated stress response correlates with anti -tumor activity of imipridones ONC201 and ONC206 in pediatric sarcomas
    Allegakoen, David V.
    Tarapore, Rohinton S.
    Allen, Joshua E.
    Sabnis, Amit J.
    Bivona, Trever G.
    CANCER RESEARCH, 2019, 79 (13)
  • [5] Impact of hypoxia on the integrated stress response activated by imipridones ONC201 and ONC206 in pediatric diffuse midline glioma cells
    Roady, Tyler J.
    Stubbs, Nolan
    Chen, Josephine
    Xia, Yutong
    Uruchurtu, Ashley Sanchez Sevilla
    Tian, Xiaobing
    Zhou, Lanlan
    El-Deiry, Wafik S.
    CANCER RESEARCH, 2024, 84 (06)
  • [6] ONC201 and ONC206: Metabolically ClipPing the wings of diffuse midline glioma
    Purow, Benjamin
    NEURO-ONCOLOGY, 2022, 24 (09) : 1452 - 1453
  • [7] ONC201 and imipridones: Anti-cancer compounds with clinical efficacy
    Prabhu, Varun Vijay
    Morrow, Sara
    Kawakibi, Abed Rahman
    Zhou, Lanlan
    Ralff, Marie
    Ray, Jocelyn
    Jhaveri, Aakash
    Ferrarini, Isacco
    Lee, Young
    Parker, Cassandra
    Zhang, Yiqun
    Borsuk, Robyn
    Chang, Wen-I
    Honeymanb, Joshua N.
    Tavora, Fabio
    Carneiro, Benedito
    Raufi, Alexander
    Huntington, Kelsey
    Carlsen, Lindsey
    Louie, Anna
    Safran, Howard
    Seyhan, Attila A.
    Tarapore, Rohinton S.
    Schalop, Lee
    Stogniew, Martin
    Allen, Joshua E.
    Oster, Wolfgang
    El-Deiry, Wafik S.
    NEOPLASIA, 2020, 22 (12): : 725 - 744
  • [8] CLINICAL EVALUATION OF THE IMIPRIDONE ONC201 IN RECURRENT GLIOBLASTOMA: PREDICTIVE AND PHARMACODYNAMIC BIOMARKER ANALYSES
    Arrillaga-Romany, Isabel
    Allen, Joshua E.
    Prabhu, Varun V.
    Tarapore, Rohinton S.
    Zloza, Andrew
    Oster, Wolfgang
    Wen, Patrick Y.
    Batchelor, Tracy
    NEURO-ONCOLOGY, 2017, 19 : 11 - 12
  • [9] A Novel Therapeutic Mechanism of Imipridones ONC201/ONC206 in MYCN-Amplified Neuroblastoma Cells via Differential Expression of Tumorigenic Proteins
    El-Soussi, Sarra
    Hanna, Reine
    Semaan, Hanna
    Khater, Amanda-Rose
    Abdallah, Jad
    Abou-Kheir, Wassim
    Abou-Antoun, Tamara
    FRONTIERS IN PEDIATRICS, 2021, 9
  • [10] Adaptation to dopamine impairs the anti-cancer effect of ONC201 and ONC206
    Zhang, Yiqun
    El-Deiry, Wafik S.
    CANCER RESEARCH, 2022, 82 (12)
12345